Background
==========

Beneficial estrogen effects in the cardiovascular system are still under investigation and have been discussed controversially \[[@B1]-[@B3]\]. Clinical benefits such as the reduction of cardiovascular mortality, as suggested by several retrospective studies, \[[@B4],[@B5]\] have not been supported by randomised \[[@B6]\] and interventional \[[@B7],[@B8]\] trials. However, there are plenty of experimental data demonstrating beneficial estrogen effects on distinct aspects of the cardiovascular system, i.e., lipid metabolism \[[@B9]\] and lipid peroxidation \[[@B10]\], post injury smooth muscle cell and neointimal proliferation \[[@B11]-[@B14]\], and the vascular tone \[[@B15]-[@B18]\]. Some of these effects are also described for phytoestrogens like genistein and daidzein which therefore may be suggested as a possible therapeutic option in postmenopausal women \[[@B19]\].

In previous organ culture experiments we have demonstrated that 17β-estradiol and the phytoestrogens genistein (with) \[[@B20]\] and daidzein (without protein tyrosine kinase activity) \[[@B21]\] were able to inhibit neointima formation after vascular injury in a dose dependent manner \[[@B22],[@B23]\]. These effects have been described in aortic rings not only from female but from male rabbits as well \[[@B24]\]. In further experiments we titrated the lowest concentrations of these three estrogens which were able to reduce neointima formation significantly and we moreover demonstrated that this effect was unlikely caused by toxicity \[[@B25]\].

The aim of this present in vitro study was to investigate whether the inhibitory estrogen effect on post injury neointima development is modulated by estrogen receptor dependent pathways. Such interactions have been demonstrated and postulated since estrogen receptors were detected in the vasculature of animals \[[@B26]\] and humans \[[@B27],[@B28]\]. The description of different subtypes of the estrogen receptor (estrogen receptor α and β) led to more speculations on cardiovascular estrogen effects in animals and humans as well \[[@B1],[@B29]-[@B32]\]. We therefore wanted to investigate whether the pure synthetic estrogen receptor antagonist 7 alpha- \[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl\]estra-1,3,5(10)-triene-3,17 beta-diol (ICI 182,780) \[[@B33]\] can modulate vascular estrogen effects.

Methods
=======

In vitro model
--------------

A total of 7 mature female New Zealand White (NZW) rabbits (Tierforschungszentrum, University of Ulm, Germany) were benumbed by shooting a bolt into the back of their heads and exsanguinated by cutting their carotid arteries. The abdomen was opened with a scalpel and the aortic vessel prepared by removal of the connective tissue. Endothelium denudation of the abdominal and thoracic aorta was then performed in all animals in situ with a 3F Fogarty catheter (Baxter Inc., Unterschleissheim, Germany) which was pushed into the vessel through an incision at the iliac bifurcation. After inflation with natrium chloride 0.9 % the balloon was pulled through the whole vessel one time. The now denuded aortas were excised by saving the adventitial tissue. Each aorta was cut into sections of 5 mm and these aortic rings were randomised into 14 groups. Three experimental test series were performed (Table [1](#T1){ref-type="table"}): 1) Effect of the pure synthetic estrogen receptor antagonist ICI 182,780 (Schering, Berlin, Germany) at concentrations of 20, 30 and 40 μM (n = 8 each). 2) Effect of 40 μM 17β-estradiol (Sigma, Deisenhofen, Germany) alone and in combination with 20 μM ICI 182,780, the lowest concentration having been found to have no effect on neointimal proliferation in test series 1 (n = 12 each). 3) Effect of 40 μM Daidzein (Sigma, Deisenhofen, Germany) and 20 μM Genistein (Sigma, Deisenhofen, Germany) alone and combined with 20 μM ICI 182,780 (n = 10 each). These concentrations of 17β-estradiol, Genistein and Daidzein have been demonstrated to be the lowest concentrations with an inhibitory effect on neointima formation previously (Figure [1](#F1){ref-type="fig"}) \[[@B25]\].

![Inhibitory effect of 17β-estradiol (**E**), genistein (**G**) and daidzein (**D**) on post-injury neointima development in concentrations of 20/30/40 μM, compared to endothelium balloon denuded (**BD**) controls (**C**) (mean ± SD). The medium of all groups contained 1 % isopropanol (**1 % iso**) and **1 % DMSO**. Compared with controls 17β-estradiol, genistein, and daidzein (\*) reduced neointima formation significantly (p = 0.05) in a concentration dependent manner. Data from Finking et al., 2000 \[[@B25]\].](1471-2261-2-13-1){#F1}

###### 

Study Protocol

  **Goup**    **1^st^ series**    **2^nd^ series**                          **3^rd^ series**
  ----------- ------------------- ----------------------------------------- -------------------------------------
  Control     Control group       Control group                             Control group
  Treatment   20 μM ICI 182,780   20 μM ICI 182,780                         20 μM ICI 182,780
  Treatment   30 μM ICI 182,780   40 μM 17β-estradiol                       20 μM genistein
  Treatment   40 μM ICI 182,780   40 μM 17β-estradiol + 20 μM ICI 182,780   20 μM genistein + 20 μM ICI 182,780
  Treatment                                                                 40 μM daidzein
  Treatment                                                                 40 μM daidzein + 20 μM ICI 182,780

Control groups were held in medium containing 1 % isopropanol (Roth, Karlsruhe, Germany) and 1% dimethyl sulphoxide (DMSO) (Sigma, Deisenhofen, Germany) because 17β-estradiol, Genistein and Daidzein were dissolved in isopropanol and DMSO of the same concentration. All aortic rings were held separately in six-well plates for 21 days at 37°C with phenol red free Dulbecco\'s modified Eagle medium (DMEM) with Ham\'s F12 (mixed 1 plus 4; Gibco, Eggenstein, Germany), containing D-glucose (4.5 g/l), 15 % fetal calf serum (fcs) (Bio Whittacker, Heidelberg, Germany) and 2,5 ml/l Penicillin-Streptomycin (Gibco, Eggenstein, Germany). The medium contained 1 % isopropanol and 1 % DMSO in all groups and was renewed together with the estrogens three times a week.

After 21 days of treatment the sections were rinsed with PBS buffer (Dulbecco\'s PBS, Gibco, Eggenstein, Germany), 500 ml PBS buffer containing 5 ml PBS^+^ basic-solution with calcium chloride dihydrate an magnesium chloride hexahydrate (Sigma, Deisenhofen, Germany).

Immunohistochemistry, morphometry, statistical evaluation
---------------------------------------------------------

The sections were fixed in 4 % formaline, embedded in paraffin, and serially cut (4 μm slices) until the maximal thickness of the neointima was reached. Haemalaun and Eosin staining was performed for a first morphological analysis. To identify smooth muscle cells and myofibroblasts among medial and neointimal cells immunohistochemical staining (biotin avidin peroxidase method) was performed with a monoclonal antibody against α-actin (mouse-anti-human; Renner Inc, Darmstadt, Germany). Elastica-van-Gieson\'s staining was performed for the morphometry of the neointima and media (software package from Bilaney Consulting Inc, Düsseldorf, Germany). The neointimal area was defined the area between lamina elastica interna and lumen. The media area was defined the area between lamina elastica interna and externa. Histomorphometry was done in a blinded fashion. The effect on neointima formation is expressed as the neointima/media ratio (median and 1^st^/3^rd^ quartile). The Wilcoxon two-sample test was used to determine statistical significance at a level of *p* = 0.05.

Results
=======

Morphoplogical aspects
----------------------

Aortic rings were morphologically intact after 21 days of cultivation and treatment as seen by microscopy. The lamina elastica interna and externa was intact as well. The media area (area between lamina elastica interna and externa) contained vascular smooth muscle cells which were made visible by α-actin staining. Sections had different amounts of neointima formation that contained vasculars mooth muscle cells surrounded by connective tissue (Figure [2](#F2){ref-type="fig"}).

![Example for neointima formation in a female rabbit aortic section after endothelial balloon denudation and 21 days of cultivation in medium containing 1 % isopropanol and 1 % DMSO. Staining with α-actin, magnification by lens × 20. Vascular smooth muscle cells are stained in the medial tissue and in the neointima.](1471-2261-2-13-2){#F2}

Effect of ICI 182,780 on post injury neointima formation
--------------------------------------------------------

Administration of ICI 182,780 in concentrations of 20, 30 and 40 μM did not cause a significant (p = 0.05) effect on post injury neointima formation (neointima/media-ratio) over 21 days (Figure [3](#F3){ref-type="fig"}). Regarding the highest concentration of 40 μM ICI 182,780 treatment the p-value did only reach 0.0875 which was in part due to the wide range of the measured data.

![The pure estrogen receptor antagonist ICI 182,780 in concentrations from 20 μM to 40 μM did not have a significant effect (p = 0.05) on post injury neointima formation. Skeletal Box-and-Whisker Plot showing (top down) maximum, 3^rd^ percentile, mean, median, 1^st^ percentile and minimum.](1471-2261-2-13-3){#F3}

Effect of 17β-estradiol on post injury neointima formation
----------------------------------------------------------

Treatment with 40 μM 17β-estradiol over 21 days (Figure [4](#F4){ref-type="fig"}) resulted in a significant (p \< 0.0001) reduction of post injury neointima formation (neointima/media-ratio). Treatment with 20 μM ICI 182,780 alone did not have an effect. Additional treatment of 20 μM ICI 182,780 with 40 μM 17β-estradiol treatment did not result in a significant reduction of the 17β-estradiol effect.

![17β-estradiol in a concentration of 40 μM caused a significant (p \< 0.0001) inhibition of post injury neointima development. This effect was not modulated by additional treatment with 20 μM of the pure antiestrogen ICI 182,780. Skeletal Box-and-Whisker Plot showing (top down) maximum, 3^rd^ percentile, mean, median, 1^st^ percentile and minimum.](1471-2261-2-13-4){#F4}

Effect of the phytoestrogens genistein and daidzein on post injury neointima formation
--------------------------------------------------------------------------------------

Treatment with 20 μM Genistein resulted in a significant (p = 0.0083) reduction of post injury neointima formation (neointima/media-ratio) after 21 days (Figure [5](#F5){ref-type="fig"}). This effect was not modulated by additional treatment with 20 μM ICI 182,780. However, treatment with 40 μM daidzein did not result in a statistically significant neointima formation (p = 0.0637) in this experiment. Additional treatment with 20 μM ICI 182,780 also did not cause a significant effect.

![Treatment with genistein 20 μM (p = 0.0083) but not with daidzein 40 μM (p = 0.0637) caused a significant inhibition of post injury neointima formation. Additional treatment with 20 μM of the pure antiestrogen ICI 182,780 did not have a significant (p = 0.05) modulating effect. Skeletal Box-and-Whisker Plot showing (top down) maximum, 3^rd^ percentile, mean, median, 1^st^ percentile and minimum.](1471-2261-2-13-5){#F5}

Discussion
==========

The purpose of this in vitro experiment was to investigate whether inhibitory estrogen and phytoestrogen effects on post injury neointima formation, as demonstrated previously \[[@B22]-[@B25]\], can be influenced by the pure synthetic estrogen receptor antagonist ICI 182,780. Because aortic rings from the whole aortic tree were used as target organs and because the lumen diameter varies between different aortas and parts of the aortic tree (thoracic and abdominal aorta), the neointima-/media-ratio was calculated as the basis for statistical analysis. In a first step the effect of different ICI 182,780 dosages from 20 μM to 40 μM was tested. These dosages corresponded to estrogen and phytoestrogen dosages that had been established as effective in this organ culture model before \[[@B25]\]. ICI 182,780 treatment in the three dosages did not cause a significant effect on post injury neointima formation (neointima-/media ratio). Focussing on neointima formation independent from the media area (data not shown) there was a statistically significant (p = 0,0392) inhibitory effect at a concentration of 40 μM ICI 182,780. Because it has been shown previously that ICI 182,780 at concentrations \>50 μM directly affects the metabolism of 17β-estradiol it did not make sense to use higher concentrations in this experiment \[[@B34]\]. In order to investigate possible interactions between an inhibitory estrogen/phytoestrogen effect on post injury neointima formation and the estrogen receptor antagonist, we used the lowest 20 μM concentration of ICI 182,780 as tested before. Treatment with 40 μM 17β-estradiol resulted in a significant reduction/inhibition of post injury neointima formation. This inhibitory effect was not influenced or modulated by additional treatment with 20 μM ICI 182,780.

Treatment with 20 μM genistein reduced post injury neointima formation significantly. This inhibitory effect could not be influenced by additional treatment with 20 μM ICI 182,780. The concentration of 40 μM daidzein did not have an inhibitory effect on post injury neointima formation, although this was demonstrated in previous experiments \[[@B25]\]. While a weak tendency of an inhibitory effect was visible in this present experiment, speculations may be allowed on the effect of higher concentrations of daidzein. Additional treatment with 20 μM ICI 182,780 did not influence the daidzein effect.

Genistein is well investigated as an inhibitor of protein tyrosine kinases \[[@B20],[@B21]\]. This may account for estrogen receptor independent antiproliferative properties. Genistein\'s analogue daidzein lacks tyrosine kinase activity which could explain the different effects in our experiment \[[@B21],[@B35],[@B36]\].

On the base of this presented data the inhibitory estrogen effect of both, 17β-estradiol and the phytoestrogens, is unlikely mediated by estrogen receptor pathways. Our data support observations from experiments with female mice which were deficient of one of the two known estrogen receptor (ER) subtypes α or β. Physiologic levels of 17β-estradiol, when compared with ovariectomized animals, were able to reduce neointimal proliferation after vascular injury in both, ER-a \[[@B37]\] and ER-β \[[@B38]\] deficient mice. Moreover, our data support findings from Dubey et al. who demonstrated that phytoestrogens like genistein and daidzein were able to inhibit human aortic smooth muscle cell proliferation and migration by estrogen receptor independent, i. e., mitogen-activated protein (MAP-) kinase modulated pathways \[[@B39]\]. The authors, too, used the synthetic ICI 182,780 for their control experiments. ICI 182,780 was first introduced by Wakeling et al. \[[@B33]\] and has been characterized as a competitive antagonists to estrogens with high affinity to the estrogen receptor and without a significant estrogenic activity itself.

But our data is in contrast to previous in vivo findings from Bakir et al. \[[@B40]\]. The authors demonstrated an inhibitory ICI 182,780 effect on 17β-estradiol induced reduction of post injury neointima formation in rat carotid arteries. However, another organ culture experiment (pulmonary arteries from hypoxic rats) by Karamsetty et al. demonstrated that 10 μM 17β-estradiol, 30 μM genistein, and 30 μM daidzein enhanced the relaxation response to carbachol. This was found to be a result of increased nitric oxide synthesis and release. But this effect could not be mediated by additional treatment with 10 μM ICI 182,780 \[[@B41]\]. The authors used estrogen and ICI 182,780 at concentrations comparable to our experiment. New findings on slow genomic (transcriptional) and rapid nongenomic (i.e., MAP kinase) estrogen effects \[[@B39],[@B42],[@B43]\] and on different estrogen receptor subtypes (estrogen receptor α and β) \[[@B1]-[@B3]\] may lead to deeper insights into the pharmacology of this system. Quite subtle ICI 182,780 effects on estrogen receptors could be demonstrated in specific cells of the sheep uterus \[[@B44]\] and in yeast genetic systems \[[@B45]\]. The acute and rapid estrogen induced calcium-dependent release of NO could be blocked by ICI 182,780 in bovine aortic endothelial cells \[[@B46]\] and in a human vascular endothelial cell (HUVEC) system \[[@B47]\].

The question remains which estrogen receptor independent mechanism(s) may have led to the demonstrated inhibitory estrogen/phytoestrogen effect on post injury neointima formation in our present experiment. Dubey et al. were able to demonstrate that not 17β-estradiol but endogenous metabolites like methoxyestradiols, with no affinity to estrogen receptors, could be responsible for ER-independent antimitogenic effects on vascular smooth muscle cells \[[@B48]\]. Metabolites like 2-methoxyestradiol and 2-hydroxyestradiol were more potent than was 17β-estradiol in inhibiting DNA synthesis, collagen synthesis, cell proliferation and migration \[[@B34]\]. Cytochrome-P450 played a key role in this local estrogen metabolism and ICI 182,780 at concentrations \>50 μM inhibited this metabolism. In addition, other nongenomic, i.e., antioxidant mechanisms have to be discussed. Yoon at al. demonstrated inhibitory 17β-estradiol effects on vascular smooth muscle cell proliferation (VSMC from rats) induced by lysophosphatidylcholine (component of oxidized LDL) or reactive oxygen species (ROS) \[[@B49]\]. The inhibitory 17β-estradiol effect was not antagonized by ICI 182,780. Furthermore, calcium antagonistic gender independent properties have been described for 17β-estradiol \[[@B15],[@B16]\] and for several phytoestrogens \[[@B50]\].

Conclusions
===========

The inhibitory effect of 17β-estradiol and the phytoestrogen genistein on post injury neointima formation has unlikely been mediated by estrogen receptor dependent pathways.
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